Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 09, 2015 6:00 PM ET


Company Overview of InteKrin Therapeutics Inc.

Company Overview

InteKrin Therapeutics Inc. is a clinical-stage biopharmaceutical company that develops and commercialize therapeutics for inflammatory and metabolic disorders. Its product includes INT-131, a peroxisome proliferator-activated receptor gamma modulator that targets inflammation and activates neuroprotective pathways. The company was founded in 2005 and is based in Redwood City, California. As of February 12, 2014, InteKrin Therapeutics Inc. operates as a subsidiary of Coherus Biosciences, Inc.

201 Redwood Shores Parkway

Suite 200

Redwood City, CA 94065

United States

Founded in 2005





Key Executives for InteKrin Therapeutics Inc.

Founder and Director
Age: 60
Chief Scientific Officer and Chief Medical Officer
Director of Russia Development
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
Pharmacyclics LLC United States
ChromaTan Corporation United States
Hemacell Perfusion, Inc. United States
Viridax Corporation United States
Partikula LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact InteKrin Therapeutics Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at